Filed: 8/14/2024ACC: 0001420506-24-001556
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 95 equity positions with a total reported market value of $574.07M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
95
Positions
$574.07M
Total AUM (reported)
46.22M
Total Shares
Allocation by class
COM$422.38M73.6%
COM NEW$72.84M12.7%
COM PAR $.01$41.92M7.3%
SPONSORED ADR$8.52M1.5%
SPONSORED ADS$8.39M1.5%
COMMON STOCK$6.69M1.2%
SHS$4.86M0.8%
Portfolio Concentration
Top 3$162.79M28.4%
4–10$169.78M29.6%
11–25$131.54M22.9%
Rest$109.96M19.2%
Top 3 weight
28.4%
Top 10 weight
57.9%
Voting Authority Distribution
Total shares with voting rights: 574.07M
Sole
Full voting authority
574.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole95
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings95
Rows:
ALNYLAM PHARMACEUTICALS INC
SOLEShares3K
TypeSH
Market value$72.90M
12.70%
Sole
72.90M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares204.61K
TypeSH
Market value$47.97M
8.36%
Sole
47.97M
Shared
0.00
None
0.00
INSMED INC
SOLEShares53.61K
TypeSH
Market value$41.92M
7.30%
Sole
41.92M
Shared
0.00
None
0.00
AMGEN INC
SOLEShares38.90K
TypeSH
Market value$30.71M
5.35%
Sole
30.71M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares7.22K
TypeSH
Market value$29.88M
5.21%
Sole
29.88M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares588.82K
TypeSH
Market value$26.37M
4.59%
Sole
26.37M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares338.01K
TypeSH
Market value$23.61M
4.11%
Sole
23.61M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares800.28K
TypeSH
Market value$21.75M
3.79%
Sole
21.75M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares41K
TypeSH
Market value$19.27M
3.36%
Sole
19.27M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares445.45K
TypeSH
Market value$18.17M
3.17%
Sole
18.17M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares309.54K
TypeSH
Market value$14.01M
2.44%
Sole
14.01M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares586.55K
TypeSH
Market value$13.71M
2.39%
Sole
13.71M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares151.60K
TypeSH
Market value$11.50M
2.00%
Sole
11.50M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares277.93K
TypeSH
Market value$9.95M
1.73%
Sole
9.95M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares170.15K
TypeSH
Market value$9.22M
1.61%
Sole
9.22M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares440.50K
TypeSH
Market value$9.19M
1.60%
Sole
9.19M
Shared
0.00
None
0.00
ALEXANDRIA REAL ESTATE EQ IN
SOLEShares733.00
TypeSH
Market value$8.57M
1.49%
Sole
8.57M
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares1.09K
TypeSH
Market value$8.52M
1.48%
Sole
8.52M
Shared
0.00
None
0.00
CATALYST PHARMACEUTICALS INC
SOLEShares518.39K
TypeSH
Market value$8.03M
1.40%
Sole
8.03M
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares138.26K
TypeSH
Market value$7.33M
1.28%
Sole
7.33M
Shared
0.00
None
0.00
PYXIS ONCOLOGY INC
SOLEShares1.67M
TypeSH
Market value$6.69M
1.17%
Sole
6.69M
Shared
0.00
None
0.00
CARTESIAN THERAPEUTICS INC
SOLEShares242.37K
TypeSH
Market value$6.55M
1.14%
Sole
6.55M
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares1.48M
TypeSH
Market value$6.51M
1.13%
Sole
6.51M
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares1.86K
TypeSH
Market value$6.04M
1.05%
Sole
6.04M
Shared
0.00
None
0.00
G1 THERAPEUTICS INC
SOLEShares25.11K
TypeSH
Market value$5.73M
1.00%
Sole
5.73M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 3K | SH | $72.90M 12.70% | 72.90M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 204.61K | SH | $47.97M 8.36% | 47.97M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 53.61K | SH | $41.92M 7.30% | 41.92M | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 38.90K | SH | $30.71M 5.35% | 30.71M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 7.22K | SH | $29.88M 5.21% | 29.88M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 588.82K | SH | $26.37M 4.59% | 26.37M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 338.01K | SH | $23.61M 4.11% | 23.61M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 800.28K | SH | $21.75M 3.79% | 21.75M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 41K | SH | $19.27M 3.36% | 19.27M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 445.45K | SH | $18.17M 3.17% | 18.17M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 309.54K | SH | $14.01M 2.44% | 14.01M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 586.55K | SH | $13.71M 2.39% | 13.71M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 151.60K | SH | $11.50M 2.00% | 11.50M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 277.93K | SH | $9.95M 1.73% | 9.95M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 170.15K | SH | $9.22M 1.61% | 9.22M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 440.50K | SH | $9.19M 1.60% | 9.19M | 0.00 | 0.00 |
ALEXANDRIA REAL ESTATE EQ INSOLE | COM | 733.00 | SH | $8.57M 1.49% | 8.57M | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 1.09K | SH | $8.52M 1.48% | 8.52M | 0.00 | 0.00 |
CATALYST PHARMACEUTICALS INCSOLE | COM | 518.39K | SH | $8.03M 1.40% | 8.03M | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 138.26K | SH | $7.33M 1.28% | 7.33M | 0.00 | 0.00 |
PYXIS ONCOLOGY INCSOLE | COMMON STOCK | 1.67M | SH | $6.69M 1.17% | 6.69M | 0.00 | 0.00 |
CARTESIAN THERAPEUTICS INCSOLE | COM NEW | 242.37K | SH | $6.55M 1.14% | 6.55M | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 1.48M | SH | $6.51M 1.13% | 6.51M | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 1.86K | SH | $6.04M 1.05% | 6.04M | 0.00 | 0.00 |
G1 THERAPEUTICS INCSOLE | COM | 25.11K | SH | $5.73M 1.00% | 5.73M | 0.00 | 0.00 |
Page 1 of 4